|
1
|
Colombo N, Carinelli S, Colombo A, Marini
C, Rollo D and Sessa C: ESMO Guidelines Working Group: Cervical
cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 23 Suppl 7:vii27–vii32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tao X, Hu W, Ramirez PT and Kavanagh JJ:
Chemotherapy for recurrent and metastatic cervical cancer. Gynecol
Oncol. 110 3 Suppl 2:S67–S71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bellmunt J, Orsola A, Leow JJ, Wiegel T,
De Santis M and Horwich A: ESMO Guidelines Working Group: Bladder
cancer: ESMO Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 25 Suppl 3:iii40–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Galloway TJ and Ridge JA: Management of
squamous cancer metastatic to cervical nodes with an unknown
primary site. J Clin Oncol. 33:3328–3337. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grossman JS: Management of metastatic
cervical cancer: Should we ignore lessons learned from treating
other advanced squamous cell cancers? J Clin Oncol. 33:965–966.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Doxsey S, McCollum D and Theurkauf W:
Centrosomes in cellular regulation. Annu Rev Cell Dev Biol.
21:411–434. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Doxsey SJ: Molecular links between
centrosome and midbody. Mol Cell. 20:170–172. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fabbro M, Zhou BB, Takahashi M, Sarcevic
B, Lal P, Graham ME, Gabrielli BG, Robinson PJ, Nigg EA, Ono Y and
Khanna KK: Cdk1/Erk2- and Plk1-dependent phosphorylation of a
centrosome protein, Cep55, is required for its recruitment to
midbody and cytokinesis. Dev Cell. 9:477–488. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Morita E, Sandrin V, Chung HY, Morham SG,
Gygi SP, Rodesch CK and Sundquist WI: Human ESCRT and ALIX proteins
interact with proteins of the midbody and function in cytokinesis.
EMBO J. 26:4215–4227. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carlton JG and Martin-Serrano J: Parallels
between cytokinesis and retroviral budding: A role for the ESCRT
machinery. Science. 316:1908–1912. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sakai M, Shimokawa T, Kobayashi T,
Matsushima S, Yamada Y, Nakamura Y and Furukawa Y: Elevated
expression of C10orf3 (chromosome 10 open reading frame 3) is
involved in the growth of human colon tumor. Oncogene. 25:480–486.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen CH, Lai JM, Chou TY, Chen CY, Su LJ,
Lee YC, Cheng TS, Hong YR, Chou CK, Whang-Peng J, et al: VEGFA
upregulates FLJ10540 and modulates migration and invasion of lung
cancer via PI3K/AKT pathway. PLoS One. 4:e50522009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen CH, Lu PJ, Chen YC, Fu SL, Wu KJ,
Tsou AP, Lee YC, Lin TC, Hsu SL, Lin WJ, et al: FLJ10540-elicited
cell transformation is through the activation of PI3-kinase/AKT
pathway. Oncogene. 26:4272–4283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
FIGO Committee on Gynecologic Oncology:
FIGO staging for carcinoma of the vulva, cervix, and corpus uteri.
Int J Gynaecol Obstet. 125:97–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marth C, Landoni F, Mahner S, McCormack M,
Gonzalez-Martin A and Colombo N: ESMO Guidelines Committee:
Cervical cancer: ESMO clinical practice guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 28:iv72–iv83. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nigg EA and Raff JW: Centrioles,
centrosomes, and cilia in health and disease. Cell. 139:663–678.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakamura M, Masuda H, Horii J, Kuma Ki,
Yokoyama N, Ohba T, Nishitani H, Miyata T, Tanaka M and Nishimoto
T: When overexpressed, a novel centrosomal protein, RanBPM, causes
ectopic microtubule nucleation similar to gamma-tubulin. J Cell
Biol. 143:1041–1052. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang W, Niu C, He W, Hou T, Sun X, Xu L
and Zhang Y: Upregulation of centrosomal protein 55 is associated
with unfavorable prognosis and tumor invasion in epithelial ovarian
carcinoma. Tumour Biol. 37:6239–6254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang YC, Wu CH, Yen TC and Ouyang P:
Centrosomal protein 55 (Cep55) stability is negatively regulated by
p53 protein through Polo-like kinase 1 (Plk1). J Biol Chem.
287:4376–4385. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tao J, Zhi X, Tian Y, Li Z, Zhu Y, Wang W,
Xie K, Tang J, Zhang X, Wang L and Xu Z: CEP55 contributes to human
gastric carcinoma by regulating cell proliferation. Tumour Biol.
35:4389–4399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen CH, Chien CY, Huang CC, Hwang CF,
Chuang HC, Fang FM, Huang HY, Chen CM, Liu HL and Huang CY:
Expression of FLJ10540 is correlated with aggressiveness of oral
cavity squamous cell carcinoma by stimulating cell migration and
invasion through increased FOXM1 and MMP-2 activity. Oncogene.
28:2723–2737. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen CH, Shiu LY, Su LJ, Huang CY, Huang
SC, Huang CC, Yin YF, Wang WS, Tsai HT, Fang FM, et al: FLJ10540 is
associated with tumor progression in nasopharyngeal carcinomas and
contributes to nasopharyngeal cell proliferation, and metastasis
via osteopontin/CD44 pathway. J Transl Med. 10:932012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hwang CF, Shiu LY, Su LJ, Yu-Fang Yin,
Wang WS, Huang SC, Chiu TJ, Huang CC, Zhen YY, Tsai HT, et al:
Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell
metastasis through the FLJ10540/AKT pathway and correlates with
poor prognosis. PLoS One. 8:e842182013. View Article : Google Scholar : PubMed/NCBI
|
